Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 2Gliosarcoma 2Glioma 2Glioblastoma 2Ependymoma 2Astrocytoma 2Sarcoma 1Optic Nerve Glioma 1Neoplasms, Neuroepithelial 1Glioma, Subependymal 1Brain Neoplasms 1

Interventions

Oncolytic Virotherapy 2Magnetic Resonance Spectroscopy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2pembrolizumab 1interferon gamma-1b 1imetelstat 1gallium Ga 68 dotatate 1fluorodopa F 18 1Verteporfin 1Valproic Acid 1Radiotherapy 1ONC206 1Interferon-gamma 1Immunotherapy 1Immunologic Techniques 1Cyproheptadine 1CLR1404 1Bevacizumab 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Neuroepithelial × fluorodopa F 18 × Sarcoma × Clear all
NCT02175745 2017-03-20

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Stanford University

Phase NA Terminated
2 enrolled 7 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Neoplasms, Neuroepithelial, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡